---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-017128"
form_type: "8-K"
ticker: "CYRX"
cik: "0001124524"
company_name: "Cryoport, Inc."
filed_at: "2022-02-09T23:59:59+00:00"
generated_at: "2026-06-27T09:29:34.971636+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Cryoport expects MVE New Prague production resumption Feb 14; $4-5M Q1 revenue impact

## Summary
- Fire on Jan 25 at MVE Biological Solutions' New Prague facility halted production.
- Production expected to resume week of Feb 14, 2022; full production ramp during Q1.
- Revenue impact of $4-5 million limited to Q1 2022.
- Insurance expected to cover majority of restoration costs and business interruption.

## SEC filing metadata
- accession: 0001104659-22-017128
- form_type: 8-K
- ticker: CYRX
- cik: 0001124524
- company_name: Cryoport, Inc.
- filed_at: 2022-02-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1124524/000110465922017128/0001104659-22-017128-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1124524/000110465922017128/tm226004d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-017128
- JSON: https://secwatch.observer/filing/0001104659-22-017128.json
- Plain text: https://secwatch.observer/filing/0001104659-22-017128.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.